You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia-Lymphoma,%20Adult%20T-Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Adult T-Cell Leukemia/Lymphoma, Lymphatic Diseases Trial in Hollywood, Boston, Chapel Hill (Brentuximab Vedotin, CHEP)

Active, not recruiting
  • Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • CHEP
  • Hollywood, Florida
  • +3 more
Nov 30, 2022

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Survival of Adult T-cell Leukemia / Lymphoma and Patients

Recruiting
  • Lymphoproliferation Induced by HTLV-1
  • +2 more
    • Paris, France
      Hôpital Necker Enfants Malades
    Sep 26, 2022

    Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

    Recruiting
    • Recurrent Adult T-Cell Leukemia/Lymphoma
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 18, 2022

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

      Not yet recruiting
      • Adult T-cell Leukemia/Lymphoma
      • +4 more
      • CC-486 (5-azacitidine)
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

      Not yet recruiting
      • Refractory Leukemia
      • +4 more
      • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
      • Dendritic Cell Vaccine
      • Miami, Florida
        University of Miami
      Jan 23, 2023

      Acute Myeloid Leukemia (AML), B-cell Non-Hodgkin's Lymphoma (B-NHL), Multiple Myeloma (MM) Trial in Shanghai (Autologous CAR-T

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • +4 more
      • Autologous CAR-T cells
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Pudong Hospital, Fudan University Affiliated Pudong Med
      Aug 22, 2022

      Biospecimen Procurement for Center for Immuno-Oncology

      Recruiting
      • Multiple Myeloma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jul 13, 2022

        Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)

        Recruiting
        • Adult T-cell Leukemia-Lymphoma
        • ATLL
        • Miami, Florida
          University of Miami
        Jan 24, 2022

        T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

        Completed
        Has Results
        • T-Cell Lymphoma Relapsed
        • +4 more
        • IL-15 plus
        • alemtuzumab
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 27, 2022

        T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

        Recruiting
        • T-cell Lymphoma
        • +30 more
        • Optional Blood Sample
        • Optional Nail Sample
        • Duarte, California
        • +25 more
        Jul 28, 2023

        T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

        Recruiting
        • T Lymphoblastic Leukemia/Lymphoma
        • CD7 CAR-T cells
        • Shenzhen, Guangdong, China
          Li Yu
        Nov 11, 2022

        T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated Trial run by the NCI (Ruxolitinib,

        Completed
        • T Cell Leukemia, Adult
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jan 26, 2022

        Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

        Active, not recruiting
        • Adult Lymphocyte Depletion Hodgkin Lymphoma
        • +16 more
        • 6,8-bis(benzylthio)octanoic acid
        • bendamustine hydrochloride
        • Winston-Salem, North Carolina
        • +1 more
        Apr 8, 2022

        Adult T-Cell Leukemia (ATL) Trial run by the NCI (LMB-2, Fludarabine, Cyclophosphamide)

        Active, not recruiting
        Has Results
        • Adult T-Cell Leukemia (ATL)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jan 13, 2022

        Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

        Recruiting
        • Acute Adult T-Cell Leukemia/Lymphoma
        • +3 more
        • Atlanta, Georgia
        • +13 more
        Jan 26, 2023

        Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)

        Active, not recruiting
        • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
        • Yamagata, Japan
          Yamagata University Hospital
        Feb 21, 2022

        T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

        Terminated
        • T-Acute Lymphoblastic Leukemia
        • Adult T Lymphoblastic Lymphoma
        • Saint Louis, Missouri
        • +1 more
        Jan 18, 2023

        T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

        Withdrawn
        • T-cell Acute Lymphoblastic Leukemia
        • T-lymphoblastic Lymphoma
        • Target CD7 CAR-T cells
        • Kunming, Yunnan, China
          920th Hospital of Joint Logistics Support Force of People's Libe
        Nov 23, 2022

        B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

        Not yet recruiting
        • B-cell Non Hodgkin Lymphoma
        • Chronic Lymphocytic Leukemia
        • Cyclophosphamide injection
        • +2 more
        • Charleston, South Carolina
          Hollings Cancer Center at Medical University of South Carolina
        Jan 18, 2023

        Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

        Not yet recruiting
        • Acute Lymphoblastic Leukemia, in Relapse
        • +5 more
        • CD19 specific Chimeric Antigen Receptor T Cell
        • Columbus, Ohio
          Nationwide Children's Hospital
        Mar 9, 2023

        Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

        Completed
        Has Results
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +20 more
        • Scottsdale, Arizona
        • +1 more
        May 6, 2022

        Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

        Recruiting
        • Lymphoblastic Leukemia
        • +5 more
        • Anti-CD19 CAR T-cells
        • Singapore, Singapore
        • +1 more
        Dec 4, 2022